Lecture 23 Flashcards

1
Q

What is genetic/genomic testing when it comes to it’s application to DNA?

A

the analysis of DNA to ID changes in gene sequence (deletions, additions or misspellings) or expression levels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is genetic/genomic testing when it comes to it’s application to RNA? (3 things)

A

the analysis of RNA to determine gene expression

or biochemical tests for the presence of gene products (proteins)

or microscopic analysis of chromosomes to ID structural variation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

describe what the future of sequencing technology is looking like and how that affects the future study of genetics

A

the cost of sequencing is rapidly decreasing

this means that the amount and types of available genetic studies looks to increase drastically in the future

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what is likely to become a routine part of medical decision making in the near future? (list and define this term)

A

pharmacogenetic testing

basically studies a pt’s genes in order to determine the perfect dose of medication based on their metabolic activity/sensitivity (that is defined by their genetic make up)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is personal genomics?

A

the science of sequencing and the art of analysis of the genome of a person for health-related decision making

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what is the relevance of the erosion of conserved binding promoter sites?

A

if enough of a pt’s genes are affected by the variants (erosions in this case) in an amount that exceeds the threshold, then those variants could be responsible for issues that correlate with people’s medical history (it could be the cause of their ailments)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

compare predictive and diagnostic genetic testing

A

Predictive: the use of a pt’s DNA sequences in deciding what medical treatments are most appropriate for that individual

Precision: using informatics (personal info) to prevent or treat disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is whole-genome/whole exome sequencing of germline DNA?

A

it is under “predictive testing”

examines the entire genome/exome to discover genetic alterations that may be the cause of a disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What factors are important in developing and validating genetic tests

A

It’s clinical validity is most important

this includes how consistently and accurately the test detects/predicts the outcome(s) of interest

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what steps must genetic tests undergo before they can be utilized regularly in the healthcare field?

A

a series of tests must be performed and then the FDA must review AND approve the test for use in healthcare systems

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

describe the pharmaco genetics of warfarin dose decision making

A

warfarin has 2 enantiomers (mirror image stereoisomers) that have different physiological potency and are metabolized differently

everyone metabolizes these enantiomers differently and at different speeds

this looks at the genetics of a pt to determine the proper dose of warfarin for them specifically

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is BRCA testing? should every get this test?

A

a test that checks for mutations in BRCA 1 and 2, which are tumor suppressor genes that are know to cause most cases of breast cancer IF they are mutated to the point where they can no longer suppress cancer tumors

no, bc BRCA gene mutations are relatively rare in the population, people should only get this test if their personal or family history suggests they may have a higher than normal risk for breast cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is Colorgaurd testing?

What specific defect does it look for?

A

an “at home, mail aways stool” DNA test that checks for colon cancer.

hypermethylation of CpG islands in gene-promoter regions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

When it comes to genetic testing for myeloid leukemia, what 3 descriptive factors for mutations in clonal hematopoiesis are associate with the risk and timing of progression to acute myeloid leukemia?

A

the number, identity, and burden of mutations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

When it comes to genetic testing for myeloid leukemia, what 3 descriptive factors for mutations in clonal hematopoiesis are associate with the risk and timing of progression to acute myeloid leukemia?

A

the number, identity, and burden of mutations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is promethease?

A

a literature retrieval system that builds a personal DNA report based on the scientific literature cited in SNPedia and a file of genotype (DNA) data

17
Q

What is promethease?

A

a literature retrieval system that builds a personal DNA report based on the scientific literature cited in SNPedia and a file of genotype (DNA) data

18
Q

What is SNPedia?

A

a website that shares information about the currently known effects of variations in DNA with their citations

19
Q

What is SNPedia?

A

a website that shares information about the currently known effects of variations in DNA with their citations

20
Q

What is the INR for a drug dose? how has pharmacogenetics changed the way it is used?

A

it is the International Normalized Ratio (INR) of drug to body weight ratio that was previously the only standard used for prescribing drugs

now the INR value is included in the calculation along with the genetic metabolic capability of the individual (still used but it is combined with pharmacogenetics)

21
Q

describe what the current literature gives, in terms of risk percentages, BRCA 1 and BRCA 2 carriers as far as their likelyhood of developing breast cancer by the age of 70 (give 2 answers).

A

BRCA1 = 55-65% chance of developing breast cancer by the age of 70

BRCA2 = 45% chance of developing breast cancer by the age of 70

22
Q

describe what the current literature gives, in terms of risk percentages, BRCA 1 and BRCA 2 carriers as far as their likely hood of developing breast cancer by the age of 70 (give 2 answers).

A

BRCA1 = 55-65% chance of developing breast cancer by the age of 70

BRCA2 = 45% chance of developing breast cancer by the age of 70

23
Q

What does it mean if a pt has “aberrantly methylated tumor suppressor genes” found in their cologuard stool sample?

A

they are at a high risk (higher as more methylation is found) to develop colorectal neoplasms